Having trouble viewing this email? View it as a Web page.
You are subscribed to updates from the Centers for Disease Control and Prevention (CDC).
UPDATE: Role of Antifungal Prophylaxis in Asymptomatic Patients
At this time, CDC does not recommend initiation of antifungal prophylaxis in exposed patients who are asymptomatic. These patients should be closely monitored for development of symptoms, with a low threshold for performing lumbar puncture should the patient become symptomatic. In addition, CDC does not recommend empiric antifungal therapy for symptomatic patients who have normal cerebrospinal fluid laboratory examination. These patients should be closely monitored and re-evaluated should their symptoms worsen.
STAY CONNECTED: CDC on Facebook CDC on Twitter
|
Thursday, October 11, 2012
What's New on the CDC Emergency Preparedness & Response Site
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment